Korean J Hepatol.
2007 Sep;13(3):301-303. 10.3350/kjhep.2007.13.3.301.
Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi, Korea.
- KMID: 760731
- DOI: http://doi.org/10.3350/kjhep.2007.13.3.301
Abstract
- No abstract available.
MeSH Terms
-
Antiviral Agents/*administration & dosage/therapeutic use
Drug Therapy, Combination
Genotype
Hepacivirus/genetics
Hepatitis C, Chronic/*drug therapy
Humans
Interferon Alfa-2a/administration & dosage/therapeutic use
Interferon Alfa-2b/administration & dosage/therapeutic use
Polyethylene Glycols/administration & dosage/therapeutic use
Ribavirin/administration & dosage/therapeutic use
Time Factors
Treatment Outcome
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment of chronic hepatitis C
- Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
- Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 1
- 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
- Prevalence of HBV Genotypes in Korean Patients with Chronic Hepatitis B
